ATMPS Ltd, a provider of blockchain-based “vein to vein” cell orchestration platforms for advanced therapies, and Ori Biotech, an innovator in cell and gene therapy (CGT) manufacturing platforms, entered a global collaboration integrate their respective data platforms to support the development of advanced therapies.
The non-exclusive partnership will result in the integration of Ori’s CGT manufacturing platform’s data architecture with ATMPS’ Hataali, a secure data sharing platform, specially designed as a scalable system for advanced therapies. The combination of the two platforms aims to provide improved product tracking, scheduling as well as live monitoring of the manufacturing status across the entire CGT supply chain from vein to vein.
